SchizophreniaArchives
A review of antipsychotic therapy effectiveness and tolerability among individuals with copy number variants relevant to schizophrenia.
Schizophrenia 1 min.
Although numerous copy number variants (CNVs) are considered pathogenic with respect to the development of schizophrenia, only eight loci have reached genome-wide significance. Reviews/studies characterizing antipsychotic use in this context exist for only three corresponding CNV syndromes. As these...
Cannabis use and first onset Schizophrenia-like psychosis after traumatic brain injury in a patient with intracranial bullet
Schizophrenia 1 min.
Traumatic brain injury (TBI) is an important cause of mortality and morbidity worldwide. Cannabis use disorder and psychosis are rare but serious comorbidities seen after TBI. Recent studies indicate that the use of cannabis for self-medication may increase after TBI. Schizophrenia-like psychosis (SLP)...
Associated factors with cannabis use among patients with schizophrenia in Morocco
Schizophrenia 1 min.
Despite its negative impact on disease progression, cannabis use remains widespread among patients with schizophrenia. This study explores the factors associated with cannabis use, which require further investigation in the Moroccan context. This cross-sectional, descriptive and analytical study was...
Neuromodulation in the treatment of social cognition dysfunction in Schizophrenia: a systematic review
Schizophrenia 7 min.
Schizophrenia affects approximately 1% of the global population1, with social cognitive dysfunction being a major contributor to the impaired functioning and suffering of these patients2. Furthermore, the impact of social cognitive dysfunction is estimated to surpass that of neurocognitive deficits3,4. Social...
